Prevalence of deleterious cardiomyopathy variants in early-onset atrial fibrillation

Insights

Genetic variants in cardiomyopathy genes are common in early-onset atrial fibrillation (AF). This finding supports genetic testing and cardiomyopathy screening for individuals diagnosed with AF at a young age.

Area of Science:

  • Cardiovascular Genetics
  • Cardiac Arrhythmias
  • Genetic Cardiology

Background:

  • Atrial fibrillation (AF) is a prevalent arrhythmia linked to significant health risks, including stroke and heart failure.
  • Emerging evidence suggests early-onset AF may indicate a higher risk for heart failure and dilated cardiomyopathy.
  • Identifying genetic predispositions in early-onset AF is crucial for understanding disease mechanisms and risk stratification.

Purpose of the Study:

  • To investigate the prevalence of genetic variants in cardiomyopathy-associated genes within a cohort of early-onset atrial fibrillation patients.
  • To analyze the relationship between age of AF onset and the presence of rare, potentially deleterious genetic variants.

Main Methods:

  • Targeted sequencing of 29 cardiomyopathy genes in 478 early-onset AF patients from a Danish cohort.
  • Whole exome sequencing analysis of 374,289 individuals from the UK Biobank, including 29,108 with AF.
  • Focus on rare, loss-of-function truncating variants and deleterious missense variants, stratified by age of AF onset.

Main Results:

  • A significant proportion (8.8%) of early-onset AF patients in the Danish cohort carried truncating variants in cardiomyopathy genes.
  • The UK Biobank analysis revealed a decreasing prevalence of truncating variants with increasing age of AF onset (3.8% for onset <45 years vs. 1.4% in controls).
  • A similar pattern was observed for the prevalence of rare missense variants.

Conclusions:

  • Deleterious genetic variants in cardiomyopathy-associated genes are highly prevalent in individuals with early-onset AF.
  • These findings support current guidelines recommending genetic evaluation for early-onset AF.
  • Genetic testing and cardiomyopathy surveillance are warranted for selected patients diagnosed with AF at a young age.
Abstract

Related Concept Videos

Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
737
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
856
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K